COMBINATORIAL PHENOTYPE-TARGETED THERAPY TO OVERCOME MECHANISMS DRIVING PROSTATE CANCER TREATMENT RESISTANCE

Fred Hutchinson Cancer Center, Seattle WA

Investigators